---
title: "Whitepaper: The in vivo tool enabling a confident transition to Phase I trials"
description: Whitepaper - The in vivo tool enabling a confident transition to Phase I trials
image: https://info.edifydigitalmedia.com/hubfs/CMP%20images/Jackson%20Labs%20-%2001.08.24/Jackson%20Labs%20CMP%20Asset%20Image%20-%2001.08.24.jpg
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Jackson Labs CMP Landing Page Banner - 01.08.24](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Jackson%20Labs%20-%2001.08.24/Jackson%20Labs%20CMP%20Landing%20Page%20Banner%20-%2001.08.24.jpg?width=2000&height=561&name=Jackson%20Labs%20CMP%20Landing%20Page%20Banner%20-%2001.08.24.jpg "Jackson Labs CMP Landing Page Banner - 01.08.24")

# Whitepaper

# The in vivo tool enabling a confident transition to Phase I trials

 

![Jackson Labs CMP Asset Image - 01.08.24](https://info.edifydigitalmedia.com/hubfs/CMP%20images/Jackson%20Labs%20-%2001.08.24/Jackson%20Labs%20CMP%20Asset%20Image%20-%2001.08.24.jpg "Jackson Labs CMP Asset Image - 01.08.24")

This paper discusses the challenges drug developers face when transitioning from preclinical discovery to clinical trials and proposes expanding the drug development toolbox with humanised mouse models.

Download the latest whitepaper to learn more about:

- The importance of selecting appropriate starting doses in clinical trials.
- Why humanised mice better predict human responses to therapeutics.
- How to integrate humanised mice into the drug development process to enhance understanding of drug behaviour, toxicity, and efficacy in humans.

 

Brought to you by 

![JAX-logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/CMP%20images/Jackson%20Labs%20CMP%20-%2002.04.24/JAX-logo.png?width=170&height=42&name=JAX-logo.png)

 

### Download Whitepaper

## Copyright 2024 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions